Beauty Health Company (The) - Warrants (04/05/2026) OverviewTrack Beauty Health Company (The) - Warrants (04/05/2026)'s EBIT ($-220M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2021
Trailing 12 months ending Sep 30, 2021
The latest EBIT for SKINW is $-220M as of September 2021. That is below the Healthcare sector average of $23B. Investors often review this figure alongside Beauty Health Company (The) - Warrants (04/05/2026)'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, SKINW currently prints $-220M for EBIT, while the sector average sits near $23B. That is roughly 101.0% below the sector mean. Large gaps often invite a closer look at Beauty Health Company (The) - Warrants (04/05/2026)'s growth, margins, and balance sheet.
A EBIT figure of $-220M for SKINW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.
After noting SKINW's EBIT ($-220M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Beauty Health Company (The) - Warrants (04/05/2026)'s EBIT against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
